Quanterix Corporation Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Quanterix Corporation (QTRX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$155.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-10
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$155.00K, a 117.36% decline year-over-year.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$290.00K, a 123.03% decline year-over-year.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $95.00K.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $110.00K, a 93.35% decline year-over-year.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $2.36M.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$1.41M, a 262.59% decline from fiscal 2023.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $866.00K.
- Quanterix Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$2.98M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$155.00K 10-Q · filed 2026-08-10 | -$445.00K 10-Q · filed 2026-08-10 | -$350.00K derived: sum of 3 quarters · filed 2026-08-10 | -$240.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$290.00K 10-Q · filed 2026-05-06 | -$195.00K derived: sum of 2 quarters · filed 2026-05-06 | -$85.00K derived: sum of 3 quarters · filed 2026-05-06 | $808.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $205.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.10M derived: sum of 3 quarters · filed 2026-08-10 | $2.36M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $110.00K 10-Q · filed 2025-11-10 | $1.00M derived: sum of 2 quarters · filed 2026-08-10 | $2.26M 10-Q · filed 2025-11-10 | $593.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $893.00K 10-Q · filed 2026-08-10 | $2.15M 10-Q · filed 2026-08-10 | $483.00K derived: sum of 3 quarters · filed 2026-08-10 | $2.14M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-06 | -$410.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.25M derived: sum of 3 quarters · filed 2026-05-06 | $1.13M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$14.00K derived: sum of 2 quarters · filed 2026-03-02 | -$127.00K derived: sum of 3 quarters · filed 2026-03-02 | -$1.41M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $1.66M 10-Q · filed 2025-11-10 | $1.54M derived: sum of 2 quarters · filed 2025-11-10 | $261.00K 10-Q · filed 2025-11-10 | $1.72M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | -$113.00K 10-Q · filed 2025-08-07 | -$1.39M 10-Q · filed 2025-08-07 | $63.00K derived: sum of 3 quarters · filed 2026-03-02 | -$326.00K derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | -$1.28M 10-Q · filed 2025-05-12 | $176.00K derived: sum of 2 quarters · filed 2026-03-02 | -$213.00K derived: sum of 3 quarters · filed 2026-03-02 | -$457.00K derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $1.46M derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02 | $1.07M derived: sum of 2 quarters · filed 2026-03-02 | $824.00K derived: sum of 3 quarters · filed 2026-03-02 | $866.00K 10-K · filed 2026-03-02 | |
| 2023-09-30 | -$389.00K 10-K/A · filed 2024-12-26 | -$633.00K derived: sum of 2 quarters · filed 2024-12-26 | -$591.00K 10-K/A · filed 2024-12-26 | -$130.00K derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-06-30 | -$244.00K 10-K/A · filed 2024-12-26 | -$202.00K 10-K/A · filed 2024-12-26 | $259.00K derived: sum of 3 quarters · filed 2025-03-17 | -$537.00K derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-03-31 | $42.00K 10-K/A · filed 2024-12-26 | $503.00K derived: sum of 2 quarters · filed 2025-03-17 | -$293.00K derived: sum of 3 quarters · filed 2025-03-17 | -$1.74M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2022-12-31 | $461.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | -$335.00K derived: sum of 2 quarters · filed 2025-03-17 | -$1.78M derived: sum of 3 quarters · filed 2025-03-17 | -$2.98M 10-K · filed 2025-03-17 | -$3.06M 10-K · filed 2023-03-06 |
| 2022-09-30 | -$796.00K 10-K/A · filed 2024-12-26 | -$2.24M derived: sum of 2 quarters · filed 2024-12-26 | -$3.44M 10-K/A · filed 2024-12-26 | -$4.05M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-06-30 | -$1.45M 10-K/A · filed 2024-12-26 | -$2.64M 10-K/A · filed 2024-12-26 | -$3.25M derived: sum of 3 quarters · filed 2024-12-26 | -$3.78M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-03-31 | -$1.20M 10-K/A · filed 2024-12-26 | -$1.81M derived: sum of 2 quarters · filed 2024-12-26 | -$2.33M derived: sum of 3 quarters · filed 2024-12-26 | -$1.94M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2021-12-31 | -$610.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | -$1.14M derived: sum of 2 quarters · filed 2024-12-26 | -$742.00K derived: sum of 3 quarters · filed 2024-12-26 | -$1.99M 10-K/A · filed 2024-12-26 | |
| 2021-09-30 | -$527.00K 10-Q · filed 2022-11-09 | -$132.00K derived: sum of 2 quarters · filed 2022-11-09 | -$1.38M 10-Q · filed 2022-11-09 | $317.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $395.00K 10-Q · filed 2022-08-08 | -$856.00K 10-Q · filed 2022-08-08 | $844.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.60M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-10 | $449.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.21M derived: sum of 3 quarters · filed 2023-03-06 | $2.38M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $2.46M derived: sum of 2 quarters · filed 2023-03-06 | $3.63M derived: sum of 3 quarters · filed 2023-03-06 | $2.59M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $760.00K 10-Q · filed 2021-11-04 | $1.93M derived: sum of 2 quarters · filed 2021-11-04 | $887.00K 10-Q · filed 2021-11-04 | $1.87M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $1.17M 10-Q · filed 2021-08-05 | $127.00K 10-Q · filed 2021-08-05 | $1.11M derived: sum of 3 quarters · filed 2022-03-01 | -$26.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$1.05M 10-Q · filed 2021-05-06 | -$65.00K derived: sum of 2 quarters · filed 2022-03-01 | -$1.20M derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$153.00K derived: sum of 2 quarters · filed 2022-03-01 | -$153.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$1.14M 10-Q · filed 2020-11-06 | -$1.14M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |